Ceva Santé Animale announces new global commercial leadership team
Libourne, 30 January 2023 – Ceva Santé Animale (Ceva), the #5 animal health company present in 110 countries worldwide, has restructured its global commercial operations with the appointment of two new high-profile vice-presidents: Andras Bolcskei new Executive Vice-President for Global Commercial Operations and Loïc Jégou, Area Vice-President for Europe.
Ceva has appointed Andras Bolcskei to its Executive Committee as Global Commercial Operations executive Vice-President. He will take over the sales area from Gabriel Rshaid, who joined Ceva’s Board of Directors on January 1, 2023. As such, he will lead the business development and activities in the 6 zones where the company operates.
Andras Bolcskei graduated in veterinary public health from the University of Utrecht (Netherlands). An executive MBA program from the European University of the Hague complements Andras’ academic background. A Hungarian citizen with an impressive international career, Andras Bolcskei has joined Ceva from Covetrus, a global animal health technology and services company, where he was President for International Business. He also has extensive experience with two major animal health companies. He spent 19 years at Pfizer Animal Health and more recently 9 years at MSD Animal Health.
Andras Bolcskei is committed to build on the successes obtained by Gabriel Rshaid, reinforcing our partnerships with our customers to continue delivering efficient solutions and services that meet their needs.
As part of this new organization, Loïc Jégou will join Andras Bolcskei’s team on February 20th as Area Vice-President for Europe, covering the entire European Area (European Union and United Kingdom). Graduated from the French National Veterinary school of Alfort, Loïc Jégou also holds an MBA from the Paris ESSEC Business School.
He has 20 years of experience in the animal health industry, successively holding positions as Marketing Director, BU Director, Country Manager and Zone Director at Sanofi, Pfizer, MSD and Covetrus. In a challenging period, Loïc’s mission will be to boost growth in Europe through a wide range of products, equipment and services.